INS and type 1 diabetes mellitus: This study concluded that adding oral verapamil once daily to a standard insulin regimen provided a safe and effective approach to promote and preserve the endogenous β-cell function, delayed β-cell loss and disease progression, and reduced insulin requirements and hypoglycemic episodes in adults with recent-onset T1D (Ovalle et al., 2018).